Costa Rica will carry out a new study to measure the effectiveness of equine serum against covid-19 explica.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from explica.co Daily Mail and Mail on Sunday newspapers.
Costa Rica begins second study of equine serum to treat Covid-19
Costa Rica begins second study of equine serum to treat Covid-19
San Jose, Feb 26 (Prensa Latina) Costa Rican researchers will begin Friday the second study of the application of equine serum to treat Covid-19.
Authorities and researchers from the Costa Rican Social Security Fund (CCSS) and the University of Costa Rica (UCR) will provide the modifications on this new study, after the first one carried out a few months after they detected a positive case to the new coronavirus in this country on March 6, 2020.
In this regard, the CCSS Executive President Román Macaya said that –along with the University of Costa Rica- they established a new protocol and treated 26 Covid-19 patients.
Public hospitals in Costa Rica began to gradually reduce the beds designated to the care of Covid-19 patients following a sustained fall in infections over recent weeks.
The Costa Rican Social Security Fund (CCSS), which manages public hospitals, said Friday that it will gradually reactivate care for other ailments, which had been suspended preserve capacity for coronavirus patients.
“We hope to recover non-Covid face-to-face care services, which at the time should have been provided virtually, and other cases such as scheduled surgeries that had to be suspended,” said Mario Ruiz Cubillo, medical manager of the CCSS.
Daily cases of Covid-19 in Costa Rica went from more than 1,200 in December to around 400 since the second week of January.
With the announcement from the Costa Rican Social Security Fund (CCSS) that the second study of the application of equine serum in Covid-19 patients is soon to begin, the scientists in charge prepare the modifications for these new tests, among which is adjusting the dose according to the patient’s weight.
According to Alberto Alape, researcher for the Clodomiro Picado Institute of the University of Costa Rica (UCR), the study involves four groups of patients who will receive different doses.
“In the first trial, a single dose was given. Some patients responded well, and in others, the medication had no effect,” Alape explained. “One interpretation of the results is that the patients were of very different characteristics; there were some of more than 150 kg and others of 60 kg, so the same dose for the patients was diluted in the patient’s mass and did not have the same result. In conclusion, for the second study, the dose will be adjusted according to the patient’s w
Costa Rica begins Covid-19 vaccination for people over 58 years plenglish.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from plenglish.com Daily Mail and Mail on Sunday newspapers.